New updates have been reported about FIZE Medical.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
FIZE Medical will feature prominently at the 2026 Society of Critical Care Medicine Congress, where new clinical data using its FIZE kUO platform will be presented as an oral abstract on March 24. The study, led by investigators at Soroka Medical Center, shows that minute‑by‑minute measurement of urine output following intravenous furosemide administration in intensive care patients can predict 30‑day mortality within the first 15 minutes.
The retrospective analysis linked higher early urine output response, captured digitally and continuously by FIZE kUO, with improved short‑term survival, positioning urine output dynamics as a potential new prognostic marker in critical care. For FIZE Medical, this peer‑reviewed spotlight at a leading critical care forum underscores the clinical relevance of its AI‑enabled fluid management platform, supports its value proposition in ICU decision support, and may strengthen commercial discussions with hospitals seeking more precise renal monitoring and fluid management tools.